Medicon Hellas S.A. (MEDIC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medicon Hellas S.A. (MEDIC) has a cash flow conversion efficiency ratio of 0.074x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.25 Million ≈ $1.46 Million USD) by net assets (€16.95 Million ≈ $19.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MEDIC net asset quality index to measure how much of total assets are equity-financed.
Medicon Hellas S.A. - Cash Flow Conversion Efficiency Trend (2014–2022)
This chart illustrates how Medicon Hellas S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Medicon Hellas S.A. (MEDIC) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Medicon Hellas S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medicon Hellas S.A. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bionano Genomics Inc
NASDAQ:BNGO
|
-0.094x |
|
Daedong Metals Co. Ltd
KQ:020400
|
-0.060x |
|
VitzroSys Co Ltd
KQ:054220
|
-0.136x |
|
Agripower France Sa
PA:ALAGP
|
-0.394x |
|
Taoping Inc
NASDAQ:TAOP
|
-0.038x |
|
Daehan Flour Mills Co Ltd
KO:001130
|
0.047x |
|
Cannabist Company Holdings Inc
NEO:CBST
|
0.161x |
|
IDT Australia Ltd
AU:IDT
|
-0.047x |
Annual Cash Flow Conversion Efficiency for Medicon Hellas S.A. (2014–2022)
The table below shows the annual cash flow conversion efficiency of Medicon Hellas S.A. from 2014 to 2022. For the full company profile with market capitalisation and key ratios, see MEDIC market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | €16.95 Million ≈ $19.82 Million |
€1.25 Million ≈ $1.46 Million |
0.074x | -77.95% |
| 2021-12-31 | €14.34 Million ≈ $16.77 Million |
€4.79 Million ≈ $5.60 Million |
0.334x | +19.76% |
| 2020-12-31 | €11.03 Million ≈ $12.89 Million |
€3.07 Million ≈ $3.59 Million |
0.279x | +76.73% |
| 2019-12-31 | €10.26 Million ≈ $11.99 Million |
€1.62 Million ≈ $1.89 Million |
0.158x | -52.07% |
| 2018-12-31 | €9.68 Million ≈ $11.32 Million |
€3.19 Million ≈ $3.73 Million |
0.329x | -46.66% |
| 2017-12-31 | €7.84 Million ≈ $9.16 Million |
€4.84 Million ≈ $5.66 Million |
0.617x | +105.22% |
| 2016-12-31 | €6.12 Million ≈ $7.16 Million |
€1.84 Million ≈ $2.15 Million |
0.301x | +586.69% |
| 2015-12-31 | €5.34 Million ≈ $6.25 Million |
€-330.21K ≈ $-386.05K |
-0.062x | -112.35% |
| 2014-12-31 | €3.58 Million ≈ $4.19 Million |
€1.79 Million ≈ $2.10 Million |
0.500x | -- |
About Medicon Hellas S.A.
Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company distributes various analyzer sysytem for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems. It al… Read more